TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - DERMAPHARM HOLDING Share Price

Certificat

DE000SN8U898

Delayed Deutsche Boerse AG 15:55:23 21/05/2024 BST
2.59 EUR +7.02% Intraday chart for TURBO UNLIMITED SHORT- OPTIONSSCHEIN OHNE STOPP-LOSS-LEVEL - DERMAPHARM HOLDING
Current month-19.60%
1 month-18.24%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
21/05/24 2.59 +7.02%
20/05/24 2.42 +0.83%
17/05/24 2.4 -2.04%
16/05/24 2.45 -2.39%
15/05/24 2.51 -3.83%

Delayed Quote Deutsche Boerse AG

Last update May 21, 2024 at 03:55 pm

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying DERMAPHARM HOLDING SE
IssuerLogo Issuer Société Générale Société Générale
WKN SN8U89
ISINDE000SN8U898
Date issued 31/08/2022
Strike 61.29
Maturity Unlimited
Parity 10 : 1
Emission price 1.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 3.04
Lowest since issue 1.26
Spread 0.02
Spread %0.77%

Company Profile

Dermapharm Holding SE is a Germany-based company engaged in manufacturing of patent-free branded pharmaceuticals. The Company operates through two segments: Branded pharmaceuticals and other healthcare products, which includes in-house development, in-house production, and distribution of branded pharmaceuticals and other healthcare products, and Parallel import business, which operates under the axicorp brand. It holds around 950 marketing authorizations for more than 250 active pharmaceutical ingredients, which are marketed as pharmaceuticals, dietary supplements or supplemental balanced diets. The Company offers its products through a number of brands, including Dekristol, Ampho Moronal, Keltican, Tromcardin, among others. It is active primarily in Germany, Switzerland and Austria. Additionally, it operates production facility in Germany. Trommsdorff & GmbH Co KG is a subsidiary of the Company.
Sector
-
More about the company

Ratings for Dermapharm Holding SE

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Dermapharm Holding SE

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
37.3 EUR
Average target price
56.9 EUR
Spread / Average Target
+52.55%
Consensus